Astellas and YASKAWA to Establish Joint Venture Focused on Cell Therapy Manufacturing
The planned joint venture will leverage Astellas' expertise in R&D and manufacturing for cell therapy and the dual arm robot ‘Maholo’, developed by YASKAWA's subsidiary, Robotic Biology Institute.
YASKAWA Electric Corporation | 06/03/2025 | By Aishwarya
Astellas Pharma and YASKAWA Sign MOU to Explore Innovative Cell Therapy Ecosystem
Astellas will contribute cell manufacturing technology, clinical development, and regulatory insights related to cell therapy, while YASKAWA will provide and develop robotics and factory automation technologies.
YASKAWA Electric Corporation | 21/05/2024 | By Abha | 185
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy